132 related articles for article (PubMed ID: 8071859)
1. Role of bradykinin in myocardial preconditioning.
Wall TM; Sheehy R; Hartman JC
J Pharmacol Exp Ther; 1994 Aug; 270(2):681-9. PubMed ID: 8071859
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart.
Kositprapa C; Ockaili RA; Kukreja RC
J Mol Cell Cardiol; 2001 Jul; 33(7):1355-62. PubMed ID: 11437541
[TBL] [Abstract][Full Text] [Related]
3. The potential antiarrhythmic effects of exogenous and endogenous bradykinin in the ischaemic rat heart in vivo.
Sun W; Wainwright CL
Coron Artery Dis; 1994 Jun; 5(6):541-50. PubMed ID: 7952414
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin protects against infarction but does not mediate ischemic preconditioning in the isolated rat heart.
Bugge E; Ytrehus K
J Mol Cell Cardiol; 1996 Dec; 28(12):2333-41. PubMed ID: 9004150
[TBL] [Abstract][Full Text] [Related]
5. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
7. Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo.
Iliodromitis EK; Tasouli A; Andreadou I; Bofilis E; Zoga A; Cokkinos P; Kremastinos DT
Eur J Pharmacol; 2004 Sep; 499(1-2):163-9. PubMed ID: 15363963
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.
Hartman JC; Kurc GM; Hullinger TG; Wall TM; Sheehy RM; Shebuski RJ
J Pharmacol Exp Ther; 1994 Sep; 270(3):1071-6. PubMed ID: 7523655
[TBL] [Abstract][Full Text] [Related]
9. The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart.
Tsuchida A; Thompson R; Olsson RA; Downey JM
J Mol Cell Cardiol; 1994 Mar; 26(3):303-11. PubMed ID: 8028014
[TBL] [Abstract][Full Text] [Related]
10. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
Pagel PS; Krolikowski JG
Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
[TBL] [Abstract][Full Text] [Related]
11. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
Das B; Sarkar C
J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
[TBL] [Abstract][Full Text] [Related]
12. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts.
Goto M; Liu Y; Yang XM; Ardell JL; Cohen MV; Downey JM
Circ Res; 1995 Sep; 77(3):611-21. PubMed ID: 7641331
[TBL] [Abstract][Full Text] [Related]
13. [-Myocardial protection by preconditioning. Experimental and clinical significance-].
Strasser R; Vogt A; Schaper W
Z Kardiol; 1996 Feb; 85(2):79-89. PubMed ID: 8650986
[TBL] [Abstract][Full Text] [Related]
14. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.
Hartman JC; Wall TM; Hullinger TG; Shebuski RJ
J Cardiovasc Pharmacol; 1993 Jun; 21(6):996-1003. PubMed ID: 7687728
[TBL] [Abstract][Full Text] [Related]
15. Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining.
Birnbaum Y; Hale SL; Kloner RA
J Mol Cell Cardiol; 1997 Feb; 29(2):657-66. PubMed ID: 9140823
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
Canyon SJ; Dobson GP
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.
Vegh A; Papp JG; Parratt J
Br J Pharmacol; 1994 Dec; 113(4):1167-72. PubMed ID: 7534181
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
[TBL] [Abstract][Full Text] [Related]
19. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
Schwartz LM; Sebbag L; Jennings RB; Reimer KA
J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
[TBL] [Abstract][Full Text] [Related]
20. Preischaemic as well as postischaemic application of a Na+/H+ exchange inhibitor reduces infarct size in pigs.
Rohmann S; Weygandt H; Minck KO
Cardiovasc Res; 1995 Dec; 30(6):945-51. PubMed ID: 8746210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]